Michael Martin
OBSERVER
pediatric
Hookipa Biotech
Austria
Biography
Dr. Michael Martin is President of Takeda Ventures, Inc. (TVI) and he is based in San Diego, CA. His professional background includes venture capital, pharma business development and broad R&D experiences with an integral role in the discovery and development of 17 innovative investigational drugs and 2 commercial products. Prior to joining TVI, Dr. Martin was most recently a member of Global Licensing and Business Development at Takeda, heading efforts for sourcing and transacting technologies and early stage pipeline programs
Research Interest
Neonatal & Pediatric Health Care, Vaccination
